¹⁸F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas

¹ Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
² Endocrine Surgical Unit, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California
³ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California

^* To whom correspondence should be addressed. E-mail: fimani{at}nucmed.com.

	Abstract

Successful treatment of pheochromocytoma requires accurate diagnosis and localization of tumors. Herein, we investigated the accuracy of PET using 3,4-dihydroxy-6-¹⁸F-fluoro-phenylalanine (¹⁸F-FDOPA), an amino acid transporter substrate, as an independent marker for detection of benign and malignant pheochromocytomas. Methods: The study comprised 25 consecutive patients (9 men, 16 women) whose median age was 51 y (range, 25–68 y), with known or suspected pheochromocytoma. Eleven patients underwent standardized ¹⁸F-FDOPA PET and 14 patients underwent ¹⁸F-FDOPA PET/CT studies, with a median of 511 MBq of ¹⁸F-FDOPA (range, 206–625 MBq). Two readers, unaware of the reports of other imaging studies and clinical data, analyzed all scans visually and quantitatively (maximum standardized uptake value [SUVmax] and maximum transverse diameter). Histology and long-term clinical follow-up served as the gold standard. Correlation between SUVmax of tumors and biochemical markers was evaluated. SUVmax of the benign and malignant tumors was compared. Results: Seventeen patients underwent surgery. Histology confirmed pheochromocytoma or paraganglioma in 11 cases (8 adrenal, including 2 malignant tumors, and 3 extraadrenal, including 1 malignant tumor). The diagnosis of pheochromocytoma was established by follow-up in 2 additional patients (1 adrenal and 1 unknown location) and ruled out in 6 patients. Visual analysis detected and localized pheochromocytoma in 11 of 13 patients without false-positive results (sensitivity, 84.6%; specificity, 100%; accuracy, 92%). These lesions had an SUVmax of 2.3–34.9 (median, 8.3). Evaluation of the false-negative cases revealed a 13 x 5 mm lesion with an SUVmax of 1.96 in 1 case; no lesion was localized in the second case using multiple additional modalities. Spearman nonparametric analysis did not show statistically significant correlation between SUVmax of the tumors and biochemical markers. The Mann–Whitney nonparametric test did not demonstrate a statistically significant difference between the SUVmax of ¹⁸F-FDOPA in malignant and benign tumors. Conclusion: ¹⁸F-FDOPA PET and PET/CT are highly sensitive and specific tools that can provide additional independent information for diagnosis and localization of benign and malignant pheochromocytomas.

Key Words: ¹⁸F-FDOPA PET, ¹⁸F-FDOPA PET/CT, pheochromocytoma, paraganglioma, adrenal gland tumor

This article has been cited by other articles:

				H. J. L. M. Timmers, C. C. Chen, J. A. Carrasquillo, M. Whatley, A. Ling, B. Havekes, G. Eisenhofer, L. Martiniova, K. T. Adams, and K. Pacak Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4757 - 4767. [Abstract] [Full Text] [PDF]

				H. Minn, S. Kauhanen, M. Seppanen, and P. Nuutila 18F-FDOPA: A Multiple-Target Molecule J. Nucl. Med., December 1, 2009; 50(12): 1915 - 1918. [Abstract] [Full Text] [PDF]

				H.-B. Fiebrich, A. H. Brouwers, M. N. Kerstens, M. E. J. Pijl, I. P. Kema, J. R. de Jong, P. L. Jager, P. H. Elsinga, R. A. J. O. Dierckx, J. E. van der Wal, et al. 6-[F-18]Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3922 - 3930. [Abstract] [Full Text] [PDF]

				D. Y. Lee and K. C. P. Li Systems Diagnostics: The Systems Approach to Molecular Imaging Am. J. Roentgenol., August 1, 2009; 193(2): 287 - 294. [Abstract] [Full Text] [PDF]